Dr. Lal Pathlabs share price
You have to be logged in to add this to Watchlist.- ₹2,706.00(-2.35%)April 17, 2025 15:29:40 PM IST
- NSE
- BSE
- Vol : 96.18K (NSE + BSE)Last 20 day avg : 263.98 K
Dr. Lal Pathlabs is trading -2.35% lower at Rs 2,706.00 as compared to its last closing price. Dr. Lal Pathlabs has been trading in the price range of 2,772.00 & 2,703.00. Dr. Lal Pathlabs has given -9.54% in this year & 7.02% in the last 5 days. Dr. Lal Pathlabs has TTM P/E ratio 59.92 as compared to the sector P/E of 22.83.There are 21 analysts who have initiated coverage on Dr. Lal Pathlabs. There are 3 analysts who have given it a strong buy rating & 10 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.The company posted a net profit of 96.70 Crores in its last quarter.Listed peers of Dr. Lal Pathlabs include Krishna Instit Of Medical Scienc (1.18%), Aster Dm Healthcare (-0.15%), Dr. Lal Pathlabs (-2.35%).The Mutual Fund holding in Dr. Lal Pathlabs was at 12.84% in 31 Mar 2025. The MF holding has increased from the last quarter. The FII holding in Dr. Lal Pathlabs was at 23.90% in 31 Mar 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Apr 20, 2025, 10:54 AM UTC
- Dividend YieldLower than industry0.88Annual dividends as a percentage of the stock price.
- P/BLower than historical values12.21The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values54.30Price-to-earnings ratio based on trailing 12-month earnings
- BetaMedium volatility0.92Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.13The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 10.73% from Rs 596.70 crore to Rs 538.90 crore, year-on-year
- The company has grown its December quarter profit by 18.94% from Rs 81.30 crore to Rs 96.70 crore, year-on-year
- The debt to equity of the company is lower than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 2,711.13
- R2
- 2,944.17
- R3
- 3,112.23
- S1
- 2,310.03
- S2
- 2,141.97
- S3
- 1,908.93
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Krishna Instit Of Medical Scienc | Bullish | 652.40 | 1.18 | 26,105.06 | 84.52 | 14.32 | - | 67.07 |
| Aster Dm Healthcare | Bullish | 499.60 | -0.15 | 24,955.67 | 203.23 | 5.45 | 0.90 | 24.92 |
| Dr. Lal Pathlabs | Neutral | 2,706.00 | -2.35 | 22,619.92 | 63.12 | 12.21 | 0.88 | 5.57 |
| Rainbow Childrens Medicare | Bullish | 1,501.90 | -0.67 | 15,252.05 | 70.52 | 12.12 | 0.20 | 59.44 |
| Vijaya Diagnostic Centre | Bullish | 1,045.00 | 5.75 | 10,725.49 | 89.73 | 16.21 | 0.10 | 36.37 |
- Promoter(s) holds a high stake in the company at 53.91%
Promoter(s) have decreased the stake in the company in last 12 months- FIIs are invested in this company
- FIIs holding has decreased by 2.92 percentage points from previous quarter
- Mutual Funds holding has increased by 2.59 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-01-30 | Quarterly Results, Dividend & Others |
| 2024-10-23 | Quarterly Results & Interim Dividend |
| 2024-08-07 | Quarterly Results & Interim Dividend |
| 2024-05-10 | Audited Results & Final Dividend |
| 2024-02-01 | Quarterly Results & Interim Dividend |
- IndustryHealthcare Facilities
- ISININE600L01024
- BSE Code539524
- NSE CodeLALPATHLAB
Dr. Lal Pathlabs is trading at 2706.00 as on Thu Apr 17 2025 09:59:40. This is -2.35% lower as compared to its previous closing price of 2771.10.
The market capitalization of Dr. Lal Pathlabs is 22619.92 Cr as on Thu Apr 17 2025 09:59:40.
The average broker rating on Dr. Lal Pathlabs is Hold. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 10 analysts have given a buy rating
- 2 analysts have given a hold rating
- 3 analysts have given a sell rating
- 3 analysts have given a strong sell rating
The 52 wk high for Dr. Lal Pathlabs is 3645.00 whereas the 52 wk low is 2168.80
Dr. Lal Pathlabs can be analyzed on the following key metrics -
- TTM P/E: 59.92
- Sector P/E: 22.83
- Dividend Yield: 0.88%
- D/E ratio: -
Dr. Lal Pathlabs reported a net profit of 357.74 Cr in 2024.
The Mutual Fund Shareholding was 12.84% at the end of 31 Mar 2025.